Adaptive Phage Therapeutics Funding: $92M Raised, Series B
Adaptive Phage Therapeutics is based in Gathersburg, MD. It has raised $92M in total funding. Latest round: Series B. Backed by Deerfield Management.
Adaptive Phage Therapeutics funding overview
Adaptive Phage Therapeutics is based in Gathersburg, MD. Adaptive Phage Therapeutics has raised $92M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2023. The round record for Adaptive Phage Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Deerfield Management.
Adaptive Phage Therapeutics at a glance
Total raised
$92M
Latest round
Series B
Latest round date
June 2023
Headquarters
Gathersburg, MD
Notable investors
Deerfield Management
Frequently asked about Adaptive Phage Therapeutics funding
How much has Adaptive Phage Therapeutics raised?
Adaptive Phage Therapeutics has raised $92M in total disclosed funding across the rounds on record.
Who has invested in Adaptive Phage Therapeutics?
Deerfield Management are named among the investors backing Adaptive Phage Therapeutics.
What was the latest Adaptive Phage Therapeutics funding round?
The most recent disclosed round is a Series B, announced in June 2023.
Where is Adaptive Phage Therapeutics based?
Adaptive Phage Therapeutics is based in Gathersburg, MD.
When did Adaptive Phage Therapeutics last raise?
The last disclosed Adaptive Phage Therapeutics round closed in June 2023 at Series B.
Totals shown for Adaptive Phage Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Gathersburg and the investors behind them below.
Companies related to Adaptive Phage Therapeutics (18)
